What is Biotech Builders Group?
Biotech Builders Group operates at the intersection of advanced engineering and life science innovation. Since its inception in 2016, the firm has specialized in the end-to-end delivery of research and development laboratories, manufacturing suites, and critical utility infrastructure. Their service model encompasses the entire project lifecycle, from pre-construction planning and commissioning to ongoing facility maintenance and emergency support. By providing turnkey solutions for complex laboratory environments, the company serves as a vital partner for pharmaceutical and biotech organizations that require precision-engineered spaces to conduct high-stakes scientific research. Their market position is defined by a focus on safety, cost-efficiency, and strict adherence to the technical requirements of the life sciences sector.
How much funding has Biotech Builders Group raised?
Biotech Builders Group has raised a total of $368K across 2 funding rounds:
Debt
$150K
Debt
$218K
Debt (2020): $150K with participation from PPP
Debt (2021): $218K led by PPP
Key Investors in Biotech Builders Group
PPP
Public-Private Partnership
What's next for Biotech Builders Group?
With the support of its recent capital, Biotech Builders Group is well-positioned to accelerate its strategic initiatives within the life science construction landscape. The company is expected to focus on scaling its project management capabilities and enhancing its commissioning services to support the increasing demand for sophisticated manufacturing suites. As the industry shifts toward more agile and modular laboratory designs, the firm will likely leverage its existing expertise to capture a larger share of the infrastructure market. Future growth will likely be driven by the integration of advanced construction technologies and the expansion of its 24/7 emergency service offerings, ensuring that clients maintain operational continuity in their mission-critical facilities. This late-stage funding context suggests a transition toward broader market penetration and the potential for long-term operational excellence in the specialized construction domain.
See full Biotech Builders Group company page
